Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #16
    Originally posted by exon View Post
    We also suffered from low enrichment problem, mostly below 2%. The template that we are using is amplicon with fusion primer (with adaptor and barcode). We have checked the template with bioanalyzer and KAPA qPCR first. Then we used 1.7 cpb in the LV Lib-L emPCR. The enrichment is lower than 2% that we suspected the cpb not optimize, emPCR failed or the problem of the template? Then we went for SV using various cpb from 0.25 to 17, again the enrichment was <2% while the positive control (from previous work fine library) is OK but cpb increased from 1.7 to 14.6.
    I am working on library instead of amplicon. I thought cpb is a relative number depending how you test you library concentration.

    Comment


    • #17
      preincubation of enrichment beads with enrichment primer

      Originally posted by HMorrison View Post
      So, did it help? We are still doing it. Current work-around is to underload the plate and simply expect to have to do two runs to get the number of reads that we routinely got up until Dec 2011. Been nearly a full year of this, now.
      Dear HMorrison,

      Yes, preincubation of the enrichment beads with the enrichment primer as you suggested worked in our LV lib-L. The problem now is that the enrichments is now suddenly 40%, while from the SV (done without preincubation step) with the same cpb (1,5) gave 5% enrichment.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Understanding Genetic Influence on Infectious Disease
        by seqadmin




        During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

        Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
        09-09-2024, 10:59 AM
      • seqadmin
        Addressing Off-Target Effects in CRISPR Technologies
        by seqadmin






        The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
        08-27-2024, 04:44 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Yesterday, 02:44 PM
      0 responses
      8 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-06-2024, 08:02 AM
      0 responses
      145 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-03-2024, 08:30 AM
      0 responses
      152 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 08-27-2024, 04:40 AM
      0 responses
      159 views
      0 likes
      Last Post seqadmin  
      Working...
      X